NeoGenomics, Inc. Aktie News

NeoGenomics, Inc. (NASDAQ:NEO ) Q1 2024 Earnings Conference Call April 30, 2024 8:30 AM ET Company Participants Kendra Sweeney - VP of IR Chris Smith - CEO Jeff Sherman - CFO Warren Stone - Chief Commercial Officer Melody Harris - Chief Operations Officer and President, Informatics Ali Olivo - EVP, General Counsel and Business Development Conference Call Participants Mark Massaro - BTIG Puneet ...

FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics, Inc. announced its first-quarter results for the period ended March 31, 2024.

FT. MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics, Inc., announced two promotions within its senior leadership team, effective immediately.

FT. MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics will report its first quarter 2024 financial results on Tuesday, April 30, 2024.

FT. MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics will present data at AACR, showing its commitment to advancing cancer patient care through innovative research & development initiatives.

FT. MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics released its 2023 ESG Report, measuring key sustainability focus areas – quality, integrity, accountability, teamwork, and innovation.

FT. MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics, Inc. will participate in the upcoming TD Cowen 44th Annual Health Care Conference in Boston, Mass.

NeoGenomics (NASDAQ: NEO) stock price popped sharply this week after the company published strong financial results. It soared to a high of $16.50, its highest point since December 29th.